Lipoxin and lipoxin analogue mediated neuroprotection and treatments
US11439615B2 · kind B2 · utility
0Cited by
33References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 9, 2018 |
| Grant date | Sep 13, 2022 |
| Priority date | — |
| Expiry date | Nov 9, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions for inhibiting or preventing neurodegeneration, specifically hippocampal, cortical, and/or retinal ganglion cell neurons (RGC), and degeneration and/or cell loss or treating related disorders and diseases comprising administering to a subject an effective amount of one or more lipoxin compounds and/or lipoxin analogues such that degeneration and/or cell loss of neurons is inhibited or prevented.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.